OPT
Price:
$3.41
Market Cap:
$12.55M
Opthea Limited is an Australian biopharmaceutical company operating at the clinical development stage, focused on discovering and commercializing treatments primarily for ophthalmic conditions. Its research and development efforts are underpinned by an intellectual property portfolio that covers Vascular Endothelial Growth Factors (VEGF) C and D, along with VEGF Receptor-3. This proprietary foundation targets diseases stemming from abnormal blood and lymphatic vessel growth or vascular leakage. The company's primary therapeutic candidate, OPT 302, is a soluble form of VEGFR-3 currently undergoing clinical evaluation. This novel agent is being developed for treating wet neovascular age-relate...[Read more]
Industry
Biotechnology
IPO Date
2020-10-16
Stock Exchange
NASDAQ
Ticker
OPT
According to Opthea Limited’s latest financial reports and current stock price. The company's current Current Ratio is 19.52. This represents a change of 221.98% compared to the average of 6.06 of the last 4 quarters.
The mean historical Current Ratio of Opthea Limited over the last ten years is 11.65. The current 19.52 Current Ratio has changed 16.65% with respect to the historical average. Over the past ten years (40 quarters), OPT's Current Ratio was at its highest in in the June 2021 quarter at 44.46. The Current Ratio was at its lowest in in the January 2007 quarter at 0.
Average
11.65
Median
6.82
Minimum
0.22
Maximum
44.46
Discovering the peaks and valleys of Opthea Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 331.34%
Maximum Annual Current Ratio = 44.46
Minimum Annual Increase = -92.50%
Minimum Annual Current Ratio = 0.22
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.22 | -92.50% |
| 2024 | 2.94 | -62.74% |
| 2023 | 7.89 | 130.51% |
| 2022 | 3.42 | -92.31% |
| 2021 | 44.46 | 331.34% |
| 2020 | 10.31 | 82.06% |
| 2019 | 5.66 | -1.53% |
| 2018 | 5.75 | -79.19% |
| 2017 | 27.63 | 233.98% |
| 2016 | 8.27 | -34.93% |
The current Current Ratio of Opthea Limited (OPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.68
5-year avg
11.79
10-year avg
11.65
Opthea Limited’s Current Ratio is greater than Mirati Therapeutics, Inc. (6.96), greater than Alpine Immune Sciences, Inc. (7.86), less than RayzeBio, Inc. Common Stock (28.69), greater than CymaBay Therapeutics, Inc. (10.96), greater than SpringWorks Therapeutics, Inc. (3.81), greater than IVERIC bio, Inc. (18.63), greater than Syneos Health, Inc. (1.13), greater than MorphoSys AG (3.08), less than Morphic Holding, Inc. (28.94), greater than Abcam plc (1.13),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.96 | $4.12B | |
| 7.86 | $4.46B | |
| 28.69 | $3.75B | |
| 10.96 | $3.73B | |
| 3.81 | $3.54B | |
| 18.63 | $5.51B | |
| 1.13 | $4.46B | |
| 3.08 | $2.86B | |
| 28.94 | $2.86B | |
| 1.13 | $5.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Opthea Limited's Current Ratio?
How is the Current Ratio calculated for Opthea Limited (OPT)?
What is the highest Current Ratio for Opthea Limited (OPT)?
What is the 3-year average Current Ratio for Opthea Limited (OPT)?
What is the 5-year average Current Ratio for Opthea Limited (OPT)?
How does the current Current Ratio for Opthea Limited (OPT) compare to its historical average?